A report published by Inui et al in the Journal of Clinical Oncology evaluated a novel regimen for the prevention of chemotherapy-induced nausea and vomiting.
Question 1 of 5
In this study, chemotherapy-naive patients with thoracic cancer were randomly assigned to receive either olanzapine at ___ mg ___ daily or placebo.
